Regeneron expects its antibody cocktail for coronavirus to enter human testing in early summer
from BioPharma Dive
Regeneron is well known for its ability to take antibodies and turn them into effective drugs. Of the seven medicines the biotech has brought to market, four are antibody-based — approved to treat a range of diseases, from asthma to carcinoma to rheumatoid arthritis.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063